04:16 PM EDT, 03/15/2024 (MT Newswires) -- Michael F MacLean, Chief Financial Officer, on March 13, 2024, sold 40,000 shares in Avidity Biosciences ( RNA ) for $980,760. Following the Form 4 filing with the SEC, MacLean has control over a total of 44,093 shares of the company, with 44,093 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1599901/000159990124000044/xslF345X03/wk-form4_1710533514.xml